Tongue Cancer Overview

Save information for later
Sign Up

Learn About Tongue Cancer

What is the definition of Tongue Cancer?
Tongue (oral) cancer can occur in different areas of the oral cavity, such as on the surface of the tongue in the mouth, or at the base of the tongue in the throat. Causes of tongue cancer include tobacco and heavy alcohol use, a weakened immune system, infection with the human papillomavirus (HPV) or a previous history of head and neck cancer. The risk of tongue cancer is higher in males. In time tongue cancers may spread to other areas of the mouth, head, and neck. Most oral cancers are squamous cell carcinomas.
What are the symptoms of Tongue Cancer?
Signs and symptoms of tongue (oral) cancer include white or red patches, a sore that will not heal, bleeding, problems with pain when swallowing, a neck or mouth lump, trouble chewing, swallowing, or moving the tongue or jaw, jaw swelling, or a sore throat.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Tongue Cancer?
Treatment is determined by the type of tongue cancer cells and may include surgery, radiation therapy, chemotherapy, or a combination.
Who are the top Tongue Cancer Local Doctors?
Elite in Tongue Cancer
Dr. Ian S. Ganly
Otolaryngology
Elite in Tongue Cancer
Dr. Ian S. Ganly
Otolaryngology

Mskcc Surgery Group

1133 York Ave, 
New York, NY 
646-888-7100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ian Ganly is an Otolaryngologist in New York, New York. Dr. Ganly is rated as an Elite provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroidectomy, and Laryngectomy.

Elite in Tongue Cancer
Dr. Patrick K. Ha
Otolaryngology
Elite in Tongue Cancer
Dr. Patrick K. Ha
Otolaryngology

University Of California San Francisco

2330 Post St, 
San Francisco, CA 
415-476-4029
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Patrick Ha is an Otolaryngologist in San Francisco, California. Dr. Ha is rated as an Elite provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Adenoid Cystic Carcinoma, Salivary Gland Tumors, Tongue Cancer, Gastrostomy, and Laryngectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Matthew E. Spector
Elite in Tongue Cancer
Dr. Matthew E. Spector
Otolaryngology
Elite in Tongue Cancer
Dr. Matthew E. Spector
Otolaryngology

Univ. Ear Nose & Throat Specialists - Eye And Ear Inst.

203 Lothrop Street, Suite 300, 
Pittsburgh, PA 
412-647-2100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew E. Spector, MD, FACS, completed his medical school training at Stritch School of Medicine, Loyola University in Chicago. He then went on to the University of Michigan where he completed his residency in Otolaryngology – Head and Neck Surgery and fellowship in Head and Neck Surgical Oncology and Microvascular Reconstruction. He was on faculty at the University of Michigan for 10 years where he served as the Director of the Head and Neck Oncology Program and Associate Director of the Head and Neck Surgical Oncology and Microvascular Reconstruction Fellowship. Dr. Spector is rated as an Elite provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Glossectomy.

View All Doctors
What are the latest Tongue Cancer Clinical Trials?
A Pilot Study Assessing Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Benign and Malignant Lesions Using the Da Vinci Robotic Surgical System
A Pilot Study Assessing Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Benign and Malignant Lesions Using the Da Vinci Robotic Surgical System
Who is this study for: Adult patients with Oral Cavity or Laryngopharynx Benign and/or Malignant Diseases that have prior trans-oral exposure
Enrollment Status: Recruiting
Publish Date: November 03, 2025
Intervention Type: Procedure
Study Phase: Not Applicable

Summary: This pilot clinical trial studies transoral robotic surgery (TORS) in treating patients with benign or malignant tumors of the head and neck. TORS is a less invasive type of surgery for head and neck cancer and may have fewer side effects and improve recovery

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized Study of Head and Neck Radiotherapy With or Without Customized 3D Printed Oral Stents
A Randomized Study of Head and Neck Radiotherapy With or Without Customized 3D Printed Oral Stents
Enrollment Status: Recruiting
Publish Date: October 08, 2025
Intervention Type: Other
Study Phase: Phase 2

Summary: This clinical trial studies the effect of customized 3 dimensional (3D) printed oral tents on patients with head and neck cancer who are receiving radiotherapy. Oral stents are made from the impression of patients' mouth and cover patients' teeth and gums during radiation therapy. A customized, 3D-printed oral stent may help to reduce mouth blisters and/or sores that may develop in patients while ...

View All Clinical Trials